Thats my takeaway also, rapidly progressing towards a phase 2a and phase 2b clinical trial with a second indication yet to be announced.
This places IHL in the big leagues alongside Compass Pathways and Mind Med, both with US$ billion market caps.
Aussie investors don’t have long before the US investors will take control of the register and price IMO. I predict a lot of regret from some punters who had all the information, all the time in the world but sold before the real value was created.
IHL Price at posting:
26.5¢ Sentiment: Buy Disclosure: Held